Integra Lifesciences Holdings (IART) Share-based Compensation Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.00% |
| Dec 31, 2025 | 2.12% |
| Sep 30, 2025 | 0.62% |
| Jun 30, 2025 | 0.47% |
| Mar 31, 2025 | -12.99% |
| Dec 31, 2024 | 5.35% |
| Sep 30, 2024 | -5.73% |
| Jun 30, 2024 | 4.63% |
| Mar 31, 2024 | 6.52% |
| Dec 31, 2023 | 3.02% |
| Sep 30, 2023 | -0.41% |
| Jun 30, 2023 | -0.79% |
| Mar 31, 2023 | -5.21% |
| Dec 31, 2022 | 2.00% |
| Sep 30, 2022 | 11.05% |
| Jun 30, 2022 | 3.44% |
| Mar 31, 2022 | 3.24% |
| Dec 31, 2021 | 7.23% |
| Sep 30, 2021 | 9.70% |
| Jun 30, 2021 | 27.65% |
| Mar 31, 2021 | 14.17% |
| Dec 31, 2020 | 7.50% |
| Sep 30, 2020 | -3.21% |
| Jun 30, 2020 | 10.56% |
| Mar 31, 2020 | 10.39% |
| Dec 31, 2019 | 10.67% |
| Sep 30, 2019 | 14.95% |
| Jun 30, 2019 | -0.19% |
| Mar 31, 2019 | 10.57% |
| Dec 31, 2018 | 17.30% |
| Sep 30, 2018 | 14.51% |
| Jun 30, 2018 | 15.29% |
| Mar 31, 2018 | 17.95% |
| Dec 31, 2017 | 16.50% |
| Sep 30, 2017 | 18.45% |
| Jun 30, 2017 | 20.01% |
| Mar 31, 2017 | 20.97% |
| Dec 31, 2016 | 11.78% |
| Sep 30, 2016 | 9.95% |
| Jun 30, 2016 | -11.22% |
| Mar 31, 2016 | -4.14% |
| Dec 31, 2015 | -8.65% |
| Sep 30, 2015 | 10.12% |
| Jun 30, 2015 | -3.16% |
| Mar 31, 2015 | -9.85% |
| Dec 31, 2014 | -3.94% |
| Sep 30, 2014 | -5.00% |